Another screenshot as we connect the dots.

I think the company is showing its true colors today.

Again, just more evidence and screenshots.

I guess we’ll see.

Obviously, people take me seriously otherwise they would not attempt to put so much effort in targeting me.

Right?

What makes this interesting is l’m a known shareholders with a large stake. And everything I’ve described in terms of conflicts of interest and excessive fees can be tied to public filings.

The company is already in litigation per excessive compensation with oral arguments scheduled for September.

So we shall see.

Ah ha.

As I said, any additional information about the parties involved would be helpful. I would keep it fully confidential except with counsel. Thanks in advance.

Some said you are the same poster as Hoff? Is that true?

Thanks.

Any additional information will help.

Good question.

I’ll be discussing fees and strategy and such next week. But for now I’ll just be collecting screen shots.

Lawsuits are very methodical.

Just letting you know.

If you’re a member of the bar (hard to believe you ever passed it), but if you are, I’m sure they would be interested to learn about your activities.

He would love to take the case. But I have someone more local. You’ll find out soon enough. As will NWBO,

We’re going to test that theory.

Now I’ve been doxxed.

Be prepared for litigation.

That’s would be liable. It might be NWBO and it’s media consultant who are now in hot water!

I would check with the status of that company. A lot of people have brought lawsuits against that company, including personal injury claims. And one poster on this board was actually involved with the CEO.

I took a quick glance, and apparently Hoff didn’t realize that in a private conversation in response to his harassing private messages that he initiated, I basically was toying with his gullibility — and yes, I’m sorry for referring to your mother as a rather loose woman.

Because Hoff is involved with what I would refer to as a conspiracy with NWBO and their media consultant, this Reddit article may become part what I and my lawyer include in discovery.

But I’ll take a closer look later.

Would like to here from Jason as well. He know who he is.

Everyone in the Poor Man Crew — please capitalize —- likes Beartrap.

The crew detests most of you dudes, but she’s an exception.

I just saw Beartrap’s post and thought it was very good. I like Beartrap, I sat three chairs down from her at my first ASM. You know me, so you’re aware I’m a busy guy. And my lawyer’s a busy guy too!

My comment from a business perspective is that Toucan already has an investment in Oncovir and Poly ICLC apparently is off patent. And not sure if the company even generates any positive cash flow.

I would be sensitive to the price that’s paid for Oncovir given those first two facts, and would want to see a fair value opinion. I think they would be smart to obtain one.

Maybe we’ll meet in discovery?

;)

How long before I know whether or not to submit my application to Gethsemani? Probably sooner than this company submits it’s application to MHRA.

Crash, it’s ridiculous that the stock is this low three years after data lock. I’m fine losing my own shirt. But a little peeved otherwise for a variety of other personal reasons.

Ya know, it’s one thing to lose your own money — I’m fine with my vow of poverty, the monastic life would suit me well. I can Gregorian Chant with the best of them. But it’s an entirely different thing to lose your family or investors money.

I’m already suspicious.

Horse, you should give credit where credit is due. I asked Zoltar the fortune teller what’s next with NWBO.

And he said the same exact thing.

Didn’t know I had a convert?

Why?

I’m Poor Man for a reason :)

I ask that question all the time. It took me a while to realize that I actually invested in a company (loosely speaking) managed by another company that in turn invested in a biotech.

I own a lot of this stock. So hope this works out.

This is an excellent post.

I would add there is now a window to settle that is in everyone’s best interest. If NWBO waits too long or asks for too much, this could drag on and the company would lose the opportunity to benefit from non dilutive capital while it experiences a liquidity shortfall.

On the other hand, if the defendants wait too long, NWBO may be in a stronger position later to continue to press for a larger settlement.

I doubt that QE takes the MTD all that seriously to use that as a reason to advise their clients not enter into a settlement now.

I stared at Woodford’s quote and just thought how really close we’ve come to the precipice after listening to the Siren’s song of this vaccine technology. The one thing that saved this company from completely falling off the cliff is that Boynton and Bosch knew what they were doing in terms of managing the trials, and LP at least took the advice of the SAB to extend the trial to show better OS numbers.

Keep in mind that the same type of financial awards and legal protections that apply to whistleblowers for Federal related cases don’t apply to private party litigation.

Whistleblower names in civil private party cases don’t remain under seal and there may not be any financial awards attached. Although I could see a whistleblower for an SEC/DOJ related case, this is far less likely than for NWBO v. Citadel. And Federal cases take a long time to investigate before bringing the charging documents.

I could easily envision a DOJ investigation of prominent market makers. But the largest market makers are constantly under the SEC microscope as is. This isn’t Rick’s Saloon. So it would take something substantially new — such as a credible whistleblower — in my opinion to bring Federal charges.

The more you describe it, the more I lean toward this being a big problem with the contractors (CROs). Correction: receipt of a LD is not accounted for as a contingency gain. I believe those are treated as an offset to project expenses.

Thanks Mav.

I don’t totally discount just bad or poorly managed contractors. But it’s worthwhile laying out all the possibilities for the delays.

Mav, that’s what I had thought. Was never sure sure why the optimization process for Flaskworks was conflated with the submission and approval process. Thanks for that response.

I know you’ve mentioned on several occasions that NWBO may be deliberately withholding the application. Besides waiting for combo results as you suggest as one possibility, are there other there other reasons to deliberately slow play the submission that might be more commercial than regulatory in nature? Any similar prior experience that you can share.

Oh, and one other question. When testing a new manufacturing device like Flaskworks, does it make sense to apply the modifications to all devices for all treatments under the Specials Program, or just a small percentage? I just can’t rap my head around why there is no Specials Revenue because Flaskworks is being optimized.

Thanks.

I want to have a framed autograph picture of you for my desk.

And place it next to the picture of Michael.

This might be a question for both you and FeMike. But in your experience, what are the possible reasons for such a lengthy delay in submitting the UK application? Is there any real benefit for waiting until Flashworks is fully optimized and operational? Can’t the amended manufacturing license be handled separately from the approval process for the vaccine?

Complete mystery to how this is being handled by management, and enormously destructive to shareholder value. I just came back from lunch and the stock is now trading at 45 cents per share.

It may be because the paywall limits a specific URL to a certain number of free articles. And I’m probably past that limit. Thanks.

We obviously go to the same fortune teller.

I would like to read the article, but it requires a paid subscription, which I’m now too poor to afford.

The chickens have come home to roost.

I’m going to attend this year’s ASM wearing an empty barrel.

I look good in oak.

Until any of this is realized, where is the cash coming from to fund the company? If this takes as long as you suggest, things will get very rocky for the stock price.